Testing effectiveness (Phase 2)Study completedNCT02289209
What this trial is testing
Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck
Who this might be right for
Recurrent Head and Neck CancerCarcinoma, Squamous Cell of Head and Neck
Dan Zandberg 48